Akari Therapeutics Plc has filed an amendment to its beneficial ownership report, shedding light on recent changes in the shareholding structure of the company. This update is significant as it highlights the ongoing adjustments within the pharmaceutical preparations industry, where ownership stakes can influence investor confidence and market dynamics.
According to the filing, MMCAP International Inc. SPC and MM Asset Management Inc. now collectively own 11,427 American Depository Shares (ADS) of Akari Therapeutics. Each ADS is convertible into 80,000 ordinary shares, which gives these entities a combined ownership of approximately 0.6% of Akari's total ordinary shares. This change was reported as of September 30, 2026.
Background
Akari Therapeutics Plc, listed on the Nasdaq under the ticker AKTX, operates within the pharmaceutical preparations sector (SIC 2834). The company is based in Tampa, Florida, and focuses on developing therapies for various medical conditions. The recent filing, dated November 13, 2026, is part of a series of disclosures that Akari has made in recent weeks, including a 10-Q filing and an 8-K report.
What the Filing Says
The Schedule 13G/A filing indicates that both MMCAP International Inc. SPC and MM Asset Management Inc. hold 11,427 ADS, with shared voting and dispositive power over these shares. The filing states, "The Reporting Person owns 11,427 American Depository Shares (NASDAQ: AKTX) of the Issuer, each convertible into 80,000 Ordinary Shares." This highlights the significant potential ownership that these shares represent.
Impact
This update may influence various stakeholders, including current and potential investors, analysts, and competitors within the pharmaceutical preparations industry. The reported ownership by MMCAP International and MM Asset Management could signal confidence in Akari’s future, potentially attracting more attention from institutional investors.
What's Next
The filing does not say what happens next.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





